aluates Reports

$ 0.0

Automative

Global Injectable Anthelmintic Drugs Market Research Report 2025

Published Date: June 2025

Report Code: QYRE-Auto-36T14120

Global Injectable Anthelmintic Drugs Market Research Report 2023

BUY CHAPTERS

Global Injectable Anthelmintic Drugs Market Research Report 2025

Code: QYRE-Auto-36T14120

Report

June 2025

Pages:79

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Novartis

Cipla Ltd

Sun Pharmaceutical Industries

Amneal Pharmaceuticals

Zoetis Inc

GlaxoSmithKline PLC

Bayer

Merck

Boehringer Ingelheim International

Injectable Anthelmintic Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Injectable Anthelmintic Drugs Market

The global market for Injectable Anthelmintic Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Injectable Anthelmintic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injectable Anthelmintic Drugs.

The Injectable Anthelmintic Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Injectable Anthelmintic Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Injectable Anthelmintic Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Injectable Anthelmintic Drugs Market Report

Report Metric	Details
Report Name	Injectable Anthelmintic Drugs Market
CAGR	5%
Segment by Type	Benzimidazoles Piperazine Imidazothiazole Spiroindoles Others
Segment by Application	Hospital Pharmacies Retail Pharmacies Online Pharmacies Veterinary Pharmacies Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Novartis, Cipla, Sun Pharmaceutical Industries, Amneal Pharmaceuticals, Zoetis, GlaxoSmithKline, Bayer, Merck, Boehringer Ingelheim International
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Injectable Anthelmintic Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Injectable Anthelmintic Drugs Market report?

Ans: The main players in the Injectable Anthelmintic Drugs Market are Novartis, Cipla, Sun Pharmaceutical Industries, Amneal Pharmaceuticals, Zoetis, GlaxoSmithKline, Bayer, Merck, Boehringer Ingelheim International

What are the Application segmentation covered in the Injectable Anthelmintic Drugs Market report?

Ans: The Applications covered in the Injectable Anthelmintic Drugs Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Veterinary Pharmacies, Others

What are the Type segmentation covered in the Injectable Anthelmintic Drugs Market report?

Ans: The Types covered in the Injectable Anthelmintic Drugs Market report are Benzimidazoles, Piperazine, Imidazothiazole, Spiroindoles, Others

Recommended Reports

Anthelmintics & Parasiticides

Injectables & Drug Delivery

General Pharmaceutical Drugs

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Injectable Anthelmintic Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Benzimidazoles

1.2.3 Piperazine

1.2.4 Imidazothiazole

1.2.5 Spiroindoles

1.2.6 Others

1.3 Market by Application

1.3.1 Global Injectable Anthelmintic Drugs Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Online Pharmacies

1.3.5 Veterinary Pharmacies

1.3.6 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Injectable Anthelmintic Drugs Market Perspective (2020-2031)

2.2 Global Injectable Anthelmintic Drugs Growth Trends by Region

2.2.1 Global Injectable Anthelmintic Drugs Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Injectable Anthelmintic Drugs Historic Market Size by Region (2020-2025)

2.2.3 Injectable Anthelmintic Drugs Forecasted Market Size by Region (2026-2031)

2.3 Injectable Anthelmintic Drugs Market Dynamics

2.3.1 Injectable Anthelmintic Drugs Industry Trends

2.3.2 Injectable Anthelmintic Drugs Market Drivers

2.3.3 Injectable Anthelmintic Drugs Market Challenges

2.3.4 Injectable Anthelmintic Drugs Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Injectable Anthelmintic Drugs Players by Revenue

3.1.1 Global Top Injectable Anthelmintic Drugs Players by Revenue (2020-2025)

3.1.2 Global Injectable Anthelmintic Drugs Revenue Market Share by Players (2020-2025)

3.2 Global Injectable Anthelmintic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Injectable Anthelmintic Drugs Revenue

3.4 Global Injectable Anthelmintic Drugs Market Concentration Ratio

3.4.1 Global Injectable Anthelmintic Drugs Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Injectable Anthelmintic Drugs Revenue in 2024

3.5 Global Key Players of Injectable Anthelmintic Drugs Head office and Area Served

3.6 Global Key Players of Injectable Anthelmintic Drugs, Product and Application

3.7 Global Key Players of Injectable Anthelmintic Drugs, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Injectable Anthelmintic Drugs Breakdown Data by Type

4.1 Global Injectable Anthelmintic Drugs Historic Market Size by Type (2020-2025)

4.2 Global Injectable Anthelmintic Drugs Forecasted Market Size by Type (2026-2031)

5 Injectable Anthelmintic Drugs Breakdown Data by Application

5.1 Global Injectable Anthelmintic Drugs Historic Market Size by Application (2020-2025)

5.2 Global Injectable Anthelmintic Drugs Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Injectable Anthelmintic Drugs Market Size (2020-2031)

6.2 North America Injectable Anthelmintic Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Injectable Anthelmintic Drugs Market Size by Country (2020-2025)

6.4 North America Injectable Anthelmintic Drugs Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Injectable Anthelmintic Drugs Market Size (2020-2031)

7.2 Europe Injectable Anthelmintic Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Injectable Anthelmintic Drugs Market Size by Country (2020-2025)

7.4 Europe Injectable Anthelmintic Drugs Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Injectable Anthelmintic Drugs Market Size (2020-2031)

8.2 Asia-Pacific Injectable Anthelmintic Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Injectable Anthelmintic Drugs Market Size by Region (2020-2025)

8.4 Asia-Pacific Injectable Anthelmintic Drugs Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Injectable Anthelmintic Drugs Market Size (2020-2031)

9.2 Latin America Injectable Anthelmintic Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Injectable Anthelmintic Drugs Market Size by Country (2020-2025)

9.4 Latin America Injectable Anthelmintic Drugs Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Injectable Anthelmintic Drugs Market Size (2020-2031)

10.2 Middle East & Africa Injectable Anthelmintic Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Injectable Anthelmintic Drugs Market Size by Country (2020-2025)

10.4 Middle East & Africa Injectable Anthelmintic Drugs Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Novartis

11.1.1 Novartis Company Details

11.1.2 Novartis Business Overview

11.1.3 Novartis Injectable Anthelmintic Drugs Introduction

11.1.4 Novartis Revenue in Injectable Anthelmintic Drugs Business (2020-2025)

11.1.5 Novartis Recent Development

11.2 Cipla

11.2.1 Cipla Company Details

11.2.2 Cipla Business Overview

11.2.3 Cipla Injectable Anthelmintic Drugs Introduction

11.2.4 Cipla Revenue in Injectable Anthelmintic Drugs Business (2020-2025)

11.2.5 Cipla Recent Development

11.3 Sun Pharmaceutical Industries

11.3.1 Sun Pharmaceutical Industries Company Details

11.3.2 Sun Pharmaceutical Industries Business Overview

11.3.3 Sun Pharmaceutical Industries Injectable Anthelmintic Drugs Introduction

11.3.4 Sun Pharmaceutical Industries Revenue in Injectable Anthelmintic Drugs Business (2020-2025)

11.3.5 Sun Pharmaceutical Industries Recent Development

11.4 Amneal Pharmaceuticals

11.4.1 Amneal Pharmaceuticals Company Details

11.4.2 Amneal Pharmaceuticals Business Overview

11.4.3 Amneal Pharmaceuticals Injectable Anthelmintic Drugs Introduction

11.4.4 Amneal Pharmaceuticals Revenue in Injectable Anthelmintic Drugs Business (2020-2025)

11.4.5 Amneal Pharmaceuticals Recent Development

11.5 Zoetis

11.5.1 Zoetis Company Details

11.5.2 Zoetis Business Overview

11.5.3 Zoetis Injectable Anthelmintic Drugs Introduction

11.5.4 Zoetis Revenue in Injectable Anthelmintic Drugs Business (2020-2025)

11.5.5 Zoetis Recent Development

11.6 GlaxoSmithKline

11.6.1 GlaxoSmithKline Company Details

11.6.2 GlaxoSmithKline Business Overview

11.6.3 GlaxoSmithKline Injectable Anthelmintic Drugs Introduction

11.6.4 GlaxoSmithKline Revenue in Injectable Anthelmintic Drugs Business (2020-2025)

11.6.5 GlaxoSmithKline Recent Development

11.7 Bayer

11.7.1 Bayer Company Details

11.7.2 Bayer Business Overview

11.7.3 Bayer Injectable Anthelmintic Drugs Introduction

11.7.4 Bayer Revenue in Injectable Anthelmintic Drugs Business (2020-2025)

11.7.5 Bayer Recent Development

11.8 Merck

11.8.1 Merck Company Details

11.8.2 Merck Business Overview

11.8.3 Merck Injectable Anthelmintic Drugs Introduction

11.8.4 Merck Revenue in Injectable Anthelmintic Drugs Business (2020-2025)

11.8.5 Merck Recent Development

11.9 Boehringer Ingelheim International

11.9.1 Boehringer Ingelheim International Company Details

11.9.2 Boehringer Ingelheim International Business Overview

11.9.3 Boehringer Ingelheim International Injectable Anthelmintic Drugs Introduction

11.9.4 Boehringer Ingelheim International Revenue in Injectable Anthelmintic Drugs Business (2020-2025)

11.9.5 Boehringer Ingelheim International Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Novartis

Cipla Ltd

Sun Pharmaceutical Industries

Amneal Pharmaceuticals

Zoetis Inc

GlaxoSmithKline PLC

Bayer

Merck

Boehringer Ingelheim International

List of Tables

Table 1. Global Injectable Anthelmintic Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Benzimidazoles

Table 3. Key Players of Piperazine

Table 4. Key Players of Imidazothiazole

Table 5. Key Players of Spiroindoles

Table 6. Key Players of Others

Table 7. Global Injectable Anthelmintic Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Injectable Anthelmintic Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Injectable Anthelmintic Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 10. Global Injectable Anthelmintic Drugs Market Share by Region (2020-2025)

Table 11. Global Injectable Anthelmintic Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 12. Global Injectable Anthelmintic Drugs Market Share by Region (2026-2031)

Table 13. Injectable Anthelmintic Drugs Market Trends

Table 14. Injectable Anthelmintic Drugs Market Drivers

Table 15. Injectable Anthelmintic Drugs Market Challenges

Table 16. Injectable Anthelmintic Drugs Market Restraints

Table 17. Global Injectable Anthelmintic Drugs Revenue by Players (2020-2025) & (US$ Million)

Table 18. Global Injectable Anthelmintic Drugs Market Share by Players (2020-2025)

Table 19. Global Top Injectable Anthelmintic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable Anthelmintic Drugs as of 2024)

Table 20. Ranking of Global Top Injectable Anthelmintic Drugs Companies by Revenue (US$ Million) in 2024

Table 21. Global 5 Largest Players Market Share by Injectable Anthelmintic Drugs Revenue (CR5 and HHI) & (2020-2025)

Table 22. Global Key Players of Injectable Anthelmintic Drugs, Headquarters and Area Served

Table 23. Global Key Players of Injectable Anthelmintic Drugs, Product and Application

Table 24. Global Key Players of Injectable Anthelmintic Drugs, Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Injectable Anthelmintic Drugs Market Size by Type (2020-2025) & (US$ Million)

Table 27. Global Injectable Anthelmintic Drugs Revenue Market Share by Type (2020-2025)

Table 28. Global Injectable Anthelmintic Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 29. Global Injectable Anthelmintic Drugs Revenue Market Share by Type (2026-2031)

Table 30. Global Injectable Anthelmintic Drugs Market Size by Application (2020-2025) & (US$ Million)

Table 31. Global Injectable Anthelmintic Drugs Revenue Market Share by Application (2020-2025)

Table 32. Global Injectable Anthelmintic Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 33. Global Injectable Anthelmintic Drugs Revenue Market Share by Application (2026-2031)

Table 34. North America Injectable Anthelmintic Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. North America Injectable Anthelmintic Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 36. North America Injectable Anthelmintic Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 37. Europe Injectable Anthelmintic Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 38. Europe Injectable Anthelmintic Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 39. Europe Injectable Anthelmintic Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 40. Asia-Pacific Injectable Anthelmintic Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 41. Asia-Pacific Injectable Anthelmintic Drugs Market Size by Region (2020-2025) & (US$ Million)

Table 42. Asia-Pacific Injectable Anthelmintic Drugs Market Size by Region (2026-2031) & (US$ Million)

Table 43. Latin America Injectable Anthelmintic Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Latin America Injectable Anthelmintic Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 45. Latin America Injectable Anthelmintic Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 46. Middle East & Africa Injectable Anthelmintic Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Middle East & Africa Injectable Anthelmintic Drugs Market Size by Country (2020-2025) & (US$ Million)

Table 48. Middle East & Africa Injectable Anthelmintic Drugs Market Size by Country (2026-2031) & (US$ Million)

Table 49. Novartis Company Details

Table 50. Novartis Business Overview

Table 51. Novartis Injectable Anthelmintic Drugs Product

Table 52. Novartis Revenue in Injectable Anthelmintic Drugs Business (2020-2025) & (US$ Million)

Table 53. Novartis Recent Development

Table 54. Cipla Company Details

Table 55. Cipla Business Overview

Table 56. Cipla Injectable Anthelmintic Drugs Product

Table 57. Cipla Revenue in Injectable Anthelmintic Drugs Business (2020-2025) & (US$ Million)

Table 58. Cipla Recent Development

Table 59. Sun Pharmaceutical Industries Company Details

Table 60. Sun Pharmaceutical Industries Business Overview

Table 61. Sun Pharmaceutical Industries Injectable Anthelmintic Drugs Product

Table 62. Sun Pharmaceutical Industries Revenue in Injectable Anthelmintic Drugs Business (2020-2025) & (US$ Million)

Table 63. Sun Pharmaceutical Industries Recent Development

Table 64. Amneal Pharmaceuticals Company Details

Table 65. Amneal Pharmaceuticals Business Overview

Table 66. Amneal Pharmaceuticals Injectable Anthelmintic Drugs Product

Table 67. Amneal Pharmaceuticals Revenue in Injectable Anthelmintic Drugs Business (2020-2025) & (US$ Million)

Table 68. Amneal Pharmaceuticals Recent Development

Table 69. Zoetis Company Details

Table 70. Zoetis Business Overview

Table 71. Zoetis Injectable Anthelmintic Drugs Product

Table 72. Zoetis Revenue in Injectable Anthelmintic Drugs Business (2020-2025) & (US$ Million)

Table 73. Zoetis Recent Development

Table 74. GlaxoSmithKline Company Details

Table 75. GlaxoSmithKline Business Overview

Table 76. GlaxoSmithKline Injectable Anthelmintic Drugs Product

Table 77. GlaxoSmithKline Revenue in Injectable Anthelmintic Drugs Business (2020-2025) & (US$ Million)

Table 78. GlaxoSmithKline Recent Development

Table 79. Bayer Company Details

Table 80. Bayer Business Overview

Table 81. Bayer Injectable Anthelmintic Drugs Product

Table 82. Bayer Revenue in Injectable Anthelmintic Drugs Business (2020-2025) & (US$ Million)

Table 83. Bayer Recent Development

Table 84. Merck Company Details

Table 85. Merck Business Overview

Table 86. Merck Injectable Anthelmintic Drugs Product

Table 87. Merck Revenue in Injectable Anthelmintic Drugs Business (2020-2025) & (US$ Million)

Table 88. Merck Recent Development

Table 89. Boehringer Ingelheim International Company Details

Table 90. Boehringer Ingelheim International Business Overview

Table 91. Boehringer Ingelheim International Injectable Anthelmintic Drugs Product

Table 92. Boehringer Ingelheim International Revenue in Injectable Anthelmintic Drugs Business (2020-2025) & (US$ Million)

Table 93. Boehringer Ingelheim International Recent Development

Table 94. Research Programs/Design for This Report

Table 95. Key Data Information from Secondary Sources

Table 96. Key Data Information from Primary Sources

Table 97. Authors List of This Report

List of Figures

Figure 1. Injectable Anthelmintic Drugs Picture

Figure 2. Global Injectable Anthelmintic Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Injectable Anthelmintic Drugs Market Share by Type: 2024 VS 2031

Figure 4. Benzimidazoles Features

Figure 5. Piperazine Features

Figure 6. Imidazothiazole Features

Figure 7. Spiroindoles Features

Figure 8. Others Features

Figure 9. Global Injectable Anthelmintic Drugs Market Size by Application (2020-2031) & (US$ Million)

Figure 10. Global Injectable Anthelmintic Drugs Market Share by Application: 2024 VS 2031

Figure 11. Hospital Pharmacies Case Studies

Figure 12. Retail Pharmacies Case Studies

Figure 13. Online Pharmacies Case Studies

Figure 14. Veterinary Pharmacies Case Studies

Figure 15. Others Case Studies

Figure 16. Injectable Anthelmintic Drugs Report Years Considered

Figure 17. Global Injectable Anthelmintic Drugs Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 18. Global Injectable Anthelmintic Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 19. Global Injectable Anthelmintic Drugs Market Share by Region: 2024 VS 2031

Figure 20. Global Injectable Anthelmintic Drugs Market Share by Players in 2024

Figure 21. Global Top Injectable Anthelmintic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable Anthelmintic Drugs as of 2024)

Figure 22. The Top 10 and 5 Players Market Share by Injectable Anthelmintic Drugs Revenue in 2024

Figure 23. North America Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. North America Injectable Anthelmintic Drugs Market Share by Country (2020-2031)

Figure 25. United States Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Canada Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Europe Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Europe Injectable Anthelmintic Drugs Market Share by Country (2020-2031)

Figure 29. Germany Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. France Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. U.K. Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Italy Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Russia Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Nordic Countries Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Asia-Pacific Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Asia-Pacific Injectable Anthelmintic Drugs Market Share by Region (2020-2031)

Figure 37. China Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Japan Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. South Korea Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Southeast Asia Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. India Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Australia Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Latin America Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Latin America Injectable Anthelmintic Drugs Market Share by Country (2020-2031)

Figure 45. Mexico Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Brazil Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Middle East & Africa Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Middle East & Africa Injectable Anthelmintic Drugs Market Share by Country (2020-2031)

Figure 49. Turkey Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Saudi Arabia Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. UAE Injectable Anthelmintic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 52. Novartis Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2020-2025)

Figure 53. Cipla Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2020-2025)

Figure 54. Sun Pharmaceutical Industries Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2020-2025)

Figure 55. Amneal Pharmaceuticals Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2020-2025)

Figure 56. Zoetis Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2020-2025)

Figure 57. GlaxoSmithKline Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2020-2025)

Figure 58. Bayer Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2020-2025)

Figure 59. Merck Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2020-2025)

Figure 60. Boehringer Ingelheim International Revenue Growth Rate in Injectable Anthelmintic Drugs Business (2020-2025)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Antiparasitic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Dewormer for Cats Market Research Report 2025

Drugs for Heartworm Disease Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Injectable Nanomedicines Market Insights Forecast to 2030

Global Injectable Drug Delivery Formulation Market Research Report 2024

Injectable Drug Packaging Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Pharmaceutical Sterile Injectables Market Research Report 2024

Global Ant Killer Market Research Report 2024

Implantable Drug Infusion Pumps Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Livestock Diagnostics Kits Market Insights Forecast to 2030

Global Anti Infectives Market Research Report 2025

Needle Free Vaccine Injectors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Ophthalmic Anti Infective Drugs Market Research Report 2025

Injection Anesthetic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Helminthic Infestations Therapeutics Market Research Report 2024

Filariasis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pharmaceutical Grade Albendazole Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Prescription Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Feed Anticoccidials Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions